| Apellido | MONTEIRO |
| Nombre | LARA J. |
| ID | 6816590 |
"Su solicitud se enviará en seg. Por favor espere."
SUGERENCIAS
Monteiro, Lara J. Autor ID: 348875 ver autor
Articulos ( 1 en total )
● Angiogenic Properties of Menstrual Stem Cells Are Impaired in Women with a History of Preeclampsia, 2019
Afiliaciones ( 1 en total )
● Universidad de Los Andes, Chile
Monteiro, Lara J. Autor ID: 3972987 ver autor
Articulos ( 1 en total )
● Angiogenic properties of menstrual stem cells are impaired in women with a history of preeclampsia, 2019
Afiliaciones ( 1 en total )
● Universidad de Los Andes, Chile
Monteiro, L. J. Autor ID: 4048116 ver autor
Articulos ( 1 en total )
● Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance, 2016
Afiliaciones ( 1 en total )
● Universidad de Los Andes, Chile
Monteiro, Lara Autor ID: 5857451 ver autor
Articulos ( 1 en total )
● UNRAVELING THE ROLE OF FOXM1 IN EARLY PREECLAMPSIA-RELATED EVENTS, 2022
Afiliaciones ( 1 en total )
● Universidad de Los Andes, Chile
Monteiro, Lara Autor ID: 8522379 ver autor
Articulos ( 1 en total )
● Predictive Screening for Inflammatory Disorders of Pregnancy Using Targeted Maternal Cell-Free RNA Assays: Proof-of-Principle Data from Large Animal and Human Cohorts, 2025
Afiliaciones ( 1 en total )
● Universidad de Los Andes, Chile
ÁREA DE TRABAJO
FIRMA SELECCIONADA COMO BASE
Monteiro, Lara J. Autor ID: 6816590 ver autor
Articulos ( 20 en total, se muestran 3 )
● Diagnostic Performance of First Trimester Screening of Preeclampsia Based on Uterine Artery Pulsatility Index and Maternal Risk Factors in Routine Clinical Use, 2020
● Diagnostic potential of peri-implant crevicular fluid microRNA-21-3p and microRNA-150-5p and extracellular vesicles in peri-implant diseases, 2021
● Early Prediction of Preeclampsia using Maternal Serum Total Cell Free DNA., 2019
Afiliaciones ( 5 en total, se muestran 3 )
● Center of Interventional Medicine for Precision and Advanced Cellular Therapy (IMPACT)
● Centro de Medicina Intervencional de Precisión y Terapia Celular Avanzada
● Ctr Intervent Med Precis & Adv Cellular Therapy
FIRMAS SELECCIONADAS PARA AGRUPAR